These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20858687)

  • 1. In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone.
    Li CR; Li Y; Li GQ; Yang XY; Zhang WX; Lou RH; Liu JF; Yuan M; Huang P; Cen S; Yu LY; Zhao LX; Jiang JD; You XF
    J Antimicrob Chemother; 2010 Nov; 65(11):2411-5. PubMed ID: 20858687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.
    Li GQ; Bai XG; Li CR; Yang XY; Hu XX; Yuan M; Zhang WX; Lou RH; Guo HY; Jiang JD; You XF
    J Antimicrob Chemother; 2012 Apr; 67(4):955-61. PubMed ID: 22210757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone.
    Sreenivas K; Amarnath PV; Mallik A; Sarnaik H; Kumar NS; Takhi M; Trehan S; Kumar MS; Iqbal J; Rajagopalan R; Chakrabarti R
    J Antimicrob Chemother; 2007 Jul; 60(1):159-61. PubMed ID: 17449889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
    Takhi M; Murugan C; Munikumar M; Bhaskarreddy KM; Singh G; Sreenivas K; Sitaramkumar M; Selvakumar N; Das J; Trehan S; Iqbal J
    Bioorg Med Chem Lett; 2006 May; 16(9):2391-5. PubMed ID: 16488606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiologic factors in urinary tract infection investigated in ambulatory setting. Community-acquired urinary tract infection: etiologic aspects and antibiotic resistance].
    Al Haddad C; Graure M; Grigore L; Niţescu R; Năşcuţiu AM; Ionescu G
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(1):17-22. PubMed ID: 20524391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of lower respiratory tract infections in elderly].
    Iakovlev SV
    Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial.
    Yuan J; Mo B; Ma Z; Lv Y; Cheng SL; Yang Y; Tong Z; Wu R; Sun S; Cao Z; Wu J; Zhu D; Chang L; Zhang Y;
    J Microbiol Immunol Infect; 2019 Feb; 52(1):35-44. PubMed ID: 30181096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
    Kwon AR; Min YH; Ryu JM; Choi DR; Shim MJ; Choi EC
    J Antimicrob Chemother; 2006 Sep; 58(3):684-8. PubMed ID: 16873394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of Cefobid in pediatric practice].
    Roszkowska-Blaim M; Szymanik-Grzelak H
    Wiad Lek; 1992 Mar; 45(5-6):197-200. PubMed ID: 1455860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
    Wang XY; Guo Q; Wang YC; Liu BQ; Liu ML; Sun LY; Guo HY
    Yao Xue Xue Bao; 2008 Aug; 43(8):819-27. PubMed ID: 18956774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
    J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
    Zhu B; Marinelli BA; Goldschmidt R; Foleno BD; Hilliard JJ; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4933-6. PubMed ID: 19646867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Acute bacterial prostatitis in Korea.
    Etienne M; Caron F
    Int J Antimicrob Agents; 2009 Aug; 34(2):185-6. PubMed ID: 19342203
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal sepsis in hospital-born babies.
    Butt T; Ahmad RN; Usman M
    J Coll Physicians Surg Pak; 2004 Feb; 14(2):125; author reply 125-6. PubMed ID: 15228882
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of bacterial urinary tract infections: presence and future.
    Wagenlehner FM; Naber KG
    Eur Urol; 2006 Feb; 49(2):235-44. PubMed ID: 16413668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbial flora and sensitivity to antibiotics in surgical abdominal infection].
    Potapov AF
    Anesteziol Reanimatol; 2004; (2):52-4. PubMed ID: 15206280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.